Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2022) 81 P133 | DOI: 10.1530/endoabs.81.P133

Virgen del Rocío University Hospital, Sevilla, Spain


Introduction: Adrenocorticotropic hormone (ACTH)-dependent Cushing’s syndrome (CS) secondary to an ectopic source is an uncommon condition, accounting for 4-5% of all cases of CS and between 9-18% of cases of ACTH-dependent CS. Although numerous malignancies have been associated with ectopic ACTH syndrome (EAS), lung neuroendocrine tumours (NETs) are the most common. Refractory hypokalemia can be the presenting feature in EAS and is seen in up to 80% of cases. We present two cases which first presented with hypokalemia, refractory to treatment with potassium supplementation and spironolactone.

Cases reports

Table 1
Gender:MaleFemale
Age: (years)6256
Clinical presentation- Hypertension- Newly diagnosed hyperglycaemia- Hyperpigmentation- Peripheral edema- Constitutional syndrome- Newly diagnosed hypertension and hyperglycaemia- Proximal myopathy- Peripheral edema
Biochemical parametersGlucose 187 mg/dlGlucose 150 mg/dl
K+ 2.5 mEq/l (3.5 – 5)K+ 2.2 mEq/l (3.5 – 5)
pH 7.56; HCO3- 49.1 mEq/l
Hormone parametersUFC 14219.7 mg/24 h (35 – 135)UFC 1268 mg/24 h (35 – 135)
ACTH > 1500 pg/ml (3.6 – 60.5)ACTH 276.9 pg/ml (3.6 – 60.5)
Tumor localizationIleumLung
Tumour size32 mm17 mm
Histopathology:Large-cell neuroendocrine carcinomaSmall-cell neuroendocrine carcinoma
Immunohistochemistry:Chromogranin and synaptophysin positive. ACTH negativeChromogranin, synaptophysin, CD56 and TTF1 positive. ACTH negative
Ki-6770-80%90%
Metastasis:++
Treatment of hypercortisolismKetoconazole + somatostatin analogsKetoconazole
OutcomeDeceasedDeceased
Survival from time of diagnosis19 days12 days
UFC: 24 h-urinary free cortisol; Chromogranin, synaptophysin and CD 56: markers of neuroendocrine differentiation. TTF-1: primary site marker (lung and thyroid)

Conclusions: We present two cases of ectopic ACTH syndrome similar in their clinical presentation (newly diagnosed hyperglycaemia and hypertension and severe hypokalemia), tumour aggressiveness and rapidly fatal outcome. Furthermore, we present a case of EAS produced by a NET from the ileum tract. To our knowledge this is extremely rare and only described in isolated case reports

Volume 81

European Congress of Endocrinology 2022

Milan, Italy
21 May 2022 - 24 May 2022

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.